Close
Loading...
CONTACT US
:
:
:
Call us at:
:
:
:
Fax:
Email:

CCL17

Products

Loading...

All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.

Background

C-C motif chemokine ligand 17 (CCL17) is a small secreted inflammatory chemokine encoded by CCL17 gene, belonging to CC chemokine subfamily and acting as selective chemoattractant for type 2 immune subsets. CCL17 is predominantly secreted by dendritic cells and epithelial barrier cells, carrying evolutionarily conserved CC chemokine receptor-binding motifs across species, serving as essential modulator for CCR4-expressing immune cell recruitment and local Th2 inflammatory cascade amplification. CCL17-mediated chemotactic signaling exerts decisive effects on guiding circulating type 2 lymphocytes to mucosal and cutaneous barrier tissues under allergic challenge conditions. Furthermore, CCL17 coordinates downstream signaling cascades governing cytokine release, tissue immune retention and hypersensitivity lesion progression to sustain localized type 2 inflammatory microenvironments. Distinct from other CC chemokines with broad immune cell affinity, CCL17 carries unique non-redundant selectivity for Th2 and regulatory immune populations, rendering it indispensable for allergic immune cell homing and type 2 inflammatory tissue pathology.

CCL17 executes biological functions via high-affinity engagement of cell-surface CCR4 chemokine receptors, triggering directional migratory signaling to drive immune cell chemotaxis toward chemokine concentration gradients at barrier lesion sites. Its conserved N-terminal receptor-binding domains enable precise tuning of immune recruitment magnitude, balancing physiological immune surveillance against pathological allergic tissue infiltration. CCL17 participates in diverse biological processes including Th2 lymphocyte chemotaxis, cutaneous/mucosal inflammatory infiltration and type 2 hypersensitivity progression. Persistent CCL17 overexpression amplifies local type 2 immune accumulation, aggravating chronic allergic inflammatory tissue damage. Therefore, CCL17 constitutes a pivotal research target for allergic immunology, barrier inflammatory disease and Th2 immune regulatory mechanisms.

Fig. 1 CCL17-CCR4 axis driving Th2/Treg infiltration and type 2 inflammation in atopic dermatitis. (OA Literature)Fig. 1 In atopic dermatitis lesions, upregulated CCL17 recruits CCR4+ Th2 and Treg cells to drive type 2 inflammatory responses and regulate tumor microenvironment via CXCL17-MDSC signaling.1

CCL17 Protein Function: Core Roles in Th2 Chemotaxis and Allergic Inflammatory Signaling

The biological functions of CCL17 are focused on CC motif CCR4 receptor binding, directional type 2 immune chemotaxis and local inflammatory amplification:

  • CCR4 Receptor Specific Binding: Selectively engages CCR4-expressing Th2, Treg and innate type 2 immune subsets.
  • Immune Cell Chemotaxis: Establishes tissue chemokine gradients to guide circulating type 2 immune cell directional migration.
  • Allergic Inflammation Amplification: Sustains local retention of hypersensitivity-associated immune cells to maintain chronic inflammatory lesions.
  • Barrier Immune Tuning: Regulates mucosal and cutaneous immune compartment composition following allergen exposure.
  • Disease Relevance: Sustained CCL17 secretion drives excessive Th2 tissue infiltration and persistent chronic allergic inflammation.

CCL17 Protein Product

Creative Biolabs offers high-quality CCL17 proteins via optimized expression systems, covering full-length CCL17 and isolated receptor-binding domain variants. These products retain native CCR4-binding conformation and intrinsic chemotactic activity, suitable for chemokine-receptor interaction, Th2 migration and anti-allergic compound screening. All CCL17 proteins undergo rigorous quality control to guarantee consistent functional performance and reliable application across diverse research platforms.

CCL17 Membrane Protein Product

Not finding the membrane protein product you need? Contact us to start your one-stop custom service!

CCL17 Stable Cell Line Product

Creative Biolabs provides custom engineered CCL17 stable cell lines, including overexpression and gene silencing models. These cell line models are optimized for chemokine signaling, Th2 migratory phenotype and anti-hypersensitivity compound response profiling. Each cell line undergoes strict validation procedures to ensure steady target expression levels and uniform functional performance across multiple experimental scenarios.

CCL17 Stable Cell Line Product

Not finding the stable cell line product you need? Contact us to start your one-stop custom service!

CCL17 Recombinant Antibody Product

High-specificity recombinant antibodies targeting CCL17 are developed with advanced antibody engineering workflows, without cross-reactivity against other CC chemokine family homologs. These antibodies receive multi-scenario functional validation, applicable to protein expression profiling, extracellular chemokine secretion detection, CCR4 receptor binding assessment and allergic research, enabling precise characterization of CCL17 expression patterns, tissue gradient distribution and functional modulation under physiological and pathological states.

CCL17 Recombinant Antibody Product

Not finding the recombinant antibody product you need? Contact us to start your one-stop custom service!

Product Features

  • Native Chemotactic Activity: Preserves endogenous CCR4 ligand binding capacity and Th2 migratory induction function, supporting accurate allergic immunology and barrier inflammation research.
  • CC Chemokine Family Specificity: Validated for stable biological activity and specific CCL17 epitope binding, delivering consistent and repeatable research readouts.
  • Hypersensitivity Compatibility: Optimized for chemokine gradient analysis, Th2 infiltration detection and anti-allergy compound discovery, supplying reliable research tools.
  • Comprehensive Customization Support: Facilitates end-to-end development of customized proteins, antibodies and stable cell lines to address diverse allergic immune research requirements.

Custom CCL17 Research Services

Beyond catalog products, Creative Biolabs offers specialized custom services for CCL17 research:

  • Custom CCL17 Protein Production: Tailored expression of CCL17 sequence variants, epitope-tagged chemokines and receptor-binding truncated constructs for CCR4 interaction and Th2 migration research.
  • Custom Antibody Development: Generation of CCL17-specific antibodies for expression detection, tissue gradient localization profiling, receptor binding evaluation and allergic inflammatory mechanism exploration.
  • Stable Cell Line Engineering: Custom CCL17-modified cell models and hypersensitivity research platforms with standardized functional validation.
  • Functional Assay Development: Design of CCL17-mediated immune chemotaxis, barrier inflammatory recruitment and type 2 immune homeostasis detection assays.

Frequently Asked Questions (FAQ)

  1. What is the primary function of CCL17?

    CCL17 is a CC chemokine ligand that selectively binds CCR4 to recruit Th2 and regulatory immune cells and amplify local allergic inflammatory response.

  2. Why is CCL17 a significant research target?

    CCL17 is the core driver of tissue Th2 infiltration during hypersensitivity; sustained secretion leads to chronic cutaneous and mucosal allergic lesions, establishing it as a vital research target.

  3. Are Creative Biolabs' CCL17 products suitable for clinical use?

    No, all CCL17 products and services are strictly for research use only, not intended for clinical diagnosis or treatment.

  4. What types of CCL17 products does Creative Biolabs offer?

    Offerings include CCL17 proteins, high-specificity recombinant antibodies and custom stable cell lines for allergic immunology and hypersensitivity research.

  5. How are CCL17 proteins validated for activity?

    CCL17 proteins undergo functional verification via CCR4 binding affinity assessment and directional immune migratory capacity evaluation.

Reference
  1. Morimura, Sohshi, et al. "Increased regulatory T cells and decreased myeloid-derived suppressor cells induced by high CCL17 levels may account for normal incidence of cancers among patients with atopic dermatitis." International Journal of Molecular Sciences 22.4 (2021): 2025. Under Open Access license CC BY 4.0, without modification. https://doi.org/10.3390/ijms22042025
Our customer service representatives are available 24 hours a day, 7 days a week. Contact Us
© 2026 Creative Biolabs. | Contact Us
Thanksgiving Sale - up to 20% off membrane proteins and stable cell lines
Membrane Proteins Stable Cell Lines
;